Last reviewed · How we verify
NCT04853654
Investigation of the Effects of Selective Exercise Training in Multiple Sclerosis
NA trial testing exercise in Multiple Sclerosis in 33 participants. Completed in 15 June 2020.
15 April 2020
Quick facts
| Lead sponsor | Sanko University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 33 |
| Start date | 15 September 2018 |
| Primary completion | 15 April 2020 |
| Estimated completion | 15 June 2020 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- exercise
Conditions studied
- Multiple Sclerosis — all drugs for Multiple Sclerosis →
- Exercise — all drugs for Exercise →
Sponsor
Sanko University
Who can join
Adults 18 to 50, any sex, with Multiple Sclerosis or Exercise. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Selective exercise programs specific to muscle groups, with the workload to be done in line with the muscle's own structure, can enable more strength to be released with less fatigue in MS, and this increase in strength can increase balance and functional activities. to determine the effects of type training (selective exercise training), eccentric and concentric training on function, balance, fatigue and muscle architecture.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04853654
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of exercise
Trials testing the same drug.
- NCT07447193 — Investigation of Pain Perception According to Gender in Individuals With Scoliosis · NA · recruiting
- NCT07448467 — Investigation of the Effectiveness of Progressive Resistance Exercise Training in the Management of Lymphedema. · NA · recruiting
- NCT07442396 — The Effectiveness of Exercise in the Treatment of Erectile Dysfunction and Premature Ejaculation · NA · recruiting
- NCT07442409 — The Effect of Ergonomics and Exercise Training on Musculoskeletal Disorders in Female Dairy Farmers · NA · recruiting
- NCT07379801 — The Musculoskeletal System During Puberty in Dancers With Scoliosis, and the Effect of an Exercise Program · NA · recruiting
Other recruiting trials for Multiple Sclerosis
Currently open trials in the same condition.
- NCT07507084 — The Effect of Internal- or External-Focused Exercise Training, Administered in Conjunction With a Cognitive Task, on Wal · NA · recruiting
- NCT07524231 — Evaluation of the Effects of Laughter Yoga · NA · recruiting
- NCT07489794 — URINARY INCONTINENCE AND PELVIC FLOOR MUSCLE ACTIVITY IN MULTIPLE SCLEROSIS · recruiting
- NCT07236684 — Identification of Factors Related to UI in Patients With MS and EMG Assessment of PFM Activity · recruiting
- NCT07500727 — Skeletal Muscle Aging and Responsiveness in Aged People With MS · NA · recruiting
Other Sanko University trials
Trials by the same sponsor.
- NCT07462338 — Validity and Reliability of Timed Up and Go Test in Dual-Task Conditions for Multiple Sclerosis Patients · enrolling by invitation
- NCT07454655 — The Effect of Percussion Massage Therapy in Stroke Patients · NA · enrolling by invitation
- NCT07435116 — Duchenne Muscular Dystrophy and the Viscoelastic Properties of Upper Limb Muscles · enrolling by invitation
- NCT07441213 — Viscous Elastic Properties of Superficial Back Muscles in Individuals With Hyperkyphosis · completed
- NCT07422064 — Validity and Reliability of the Six-Minute Pegboard Ring Test in Individuals With Parkinson's Disease · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04853654 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Sanko University
- Last refreshed: 13 January 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04853654.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing